Common use of Additional Technology Clause in Contracts

Additional Technology. During the Development Program Term, if SB or Aphton believe that technology related to the subject matter of the Development Program that is controlled by a Third Person, which may include new lmmunogens, adjuvants and/or Blocking Patents ("Additional Technology") would be valuable or necessary to the Development Program in the Field hereunder Aphton or SB as appropriate shall present such Additional Technology to the Steering Committee along with a written report. The Steering Committee shall then determine, except for Blocking Patents which shall be at SB's sole discretion subject to other provisions contained herein, whether licenses to, and/or acquisitions of, such Additional ------------------------ * The redacted portions of this document have been omitted pursuant to a request for confidential treatment and such redacted portions have been filed separately with the Securities and Exchange Commission. Technology should be made, and SB shall approach and negotiate the terms of any agreement(s) with any Third Person including, without limitation payments for sponsored research. No such Third Person license and/or acquisition shall be effective with respect to SB unless and until SB has specifically agreed in writing to abide by the applicable terms and conditions of any such license and/or acquisition.

Appears in 2 contracts

Sources: Collaboration and License Agreement (Aphton Corp), Collaboration and License Agreement (Aphton Corp)